PriceTargets.com logo

IMAC - IMAC Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $5.50
  • Forecasted Upside: 3,026.78%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.18 As of 03/24/2023 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for IMAC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New IMAC Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IMAC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IMAC

Analyst Price Target is $5.50
▲ +3,026.78% Upside Potential
This price target is based on 0 analysts offering 12 month price targets for IMAC in the last 3 months. The average price target is $5.50, with a high forecast of $5.50 and a low forecast of $5.50. The average price target represents a 3,026.78% upside from the last price of $0.18.

This chart shows the closing price for IMAC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in IMAC. This rating has held steady since July 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
10/2/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/16/2022Ascendiant Capital MarketsLower TargetNA$5.50N/A
8/20/2021Industrial Alliance SecuritiesDowngradeHold$1.80Low
8/19/2021National Alliance SecuritiesDowngradeBuy ➝ Neutral$2.35 ➝ $1.75Low
8/19/2021Alliance Global PartnersDowngradeBuy ➝ NeutralLow
4/9/2021Alliance Global PartnersLower TargetPositive ➝ Buy$3.10 ➝ $2.35Low
11/17/2020Alliance Global PartnersInitiated CoverageBuy$2.75Low
4/15/2020Ascendiant Capital MarketsInitiated CoverageBuy$4.50Medium
1/14/2020Dawson JamesReiterated RatingBuy ➝ NeutralLow
(Data available from 3/26/2018 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 6 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2022
  • 0 very positive mentions
  • 8 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2023

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
IMAC logo
IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.
Read More

Today's Range

Now: $0.18
Low: $0.17
High: $0.18

50 Day Range

MA: $0.25
Low: $0.16
High: $0.37

52 Week Range

Now: $0.18
Low: $0.75
High: $1.65

Volume

309,282 shs

Average Volume

708,132 shs

Market Capitalization

$4.66 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of IMAC?

The following Wall Street research analysts have issued research reports on IMAC in the last twelve months: Ascendiant Capital Markets.
View the latest analyst ratings for IMAC.

What is the current price target for IMAC?

1 Wall Street analysts have set twelve-month price targets for IMAC in the last year. Their average twelve-month price target is $5.50, suggesting a possible upside of 3,026.8%. Ascendiant Capital Markets has the highest price target set, predicting IMAC will reach $5.50 in the next twelve months. Ascendiant Capital Markets has the lowest price target set, forecasting a price of $5.50 for IMAC in the next year.
View the latest price targets for IMAC.

What is the current consensus analyst rating for IMAC?

IMAC currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for IMAC.

What other companies compete with IMAC?

Other companies that are similar to IMAC include bioAffinity Technologies, Sonoma Pharmaceuticals, Trevena, Salarius Pharmaceuticals and Exicure. Learn More about companies similar to IMAC.

How do I contact IMAC's investor relations team?

IMAC's physical mailing address is 1605 WESTGATE CIRCLE, BRENTWOOD TN, 37027. The company's listed phone number is (844) 266-4622 and its investor relations email address is [email protected] The official website for IMAC is www.imacregeneration.com. Learn More about contacing IMAC investor relations.